Product Information
DEXTROAMPH-AMPHET ER 25 MG CAP is a generic product labeled by SpecGx LLC, priced at $7.9438 per EA under NDC 00406080301. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Aug 31, 2023. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMPH-AMPHET ER 25 MG CAP
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATEStrength
6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
SpecGx LLCNDC
00406080301
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA211546FDA Approved
8/31/2023
TE Code
AB2
On Market Since
11/1/2023
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPH-AMPHET ER 25 MG CAP has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9438 per EA |
|---|---|
| All-time high | $8.7095 (Aug 13, 2025) |
| All-time low | $7.8135 (May 22, 2024) |
| 52-week high | $8.6232 |
| 52-week low | $7.9438 |
| Median price | $8.3650 |
| Average price | $8.3397 |
| Largest weekly change | +6.0% (Jun 19, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMPH-AMPHET ER 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPH-AMPHET ER 25 MG CAP, manufactured by SpecGx LLC, is $7.9438 per EA (NDC 00406080301), effective Aug 19, 2026.
How has the price of DEXTROAMPH-AMPHET ER 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMPH-AMPHET ER 25 MG CAP has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DEXTROAMPH-AMPHET ER 25 MG CAP?
Since Apr 17, 2024, the NADAC for DEXTROAMPH-AMPHET ER 25 MG CAP has ranged from a low of $7.8135 (May 22, 2024) to a high of $8.7095 (Aug 13, 2025), with a median of $8.3650 per EA.
Are there cheaper alternatives to DEXTROAMPH-AMPHET ER 25 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMPH-AMPHET ER 25 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMPH-AMPHET ER 25 MG CAP?
DEXTROAMPH-AMPHET ER 25 MG CAP (NDC 00406080301) is labeled by SpecGx LLC, and CMS classifies it as a generic product.